Commentary on Skulberg et al.: Naloxone administration-finding the balance

Addiction. 2022 Jun;117(6):1668-1669. doi: 10.1111/add.15887. Epub 2022 Apr 7.

Authors

Marianne Jauncey^{1

2

3}, Mark Bartlett¹, Amanda Roxburgh^{2

3

4

5}

Affiliations

¹ Uniting Medically Supervised Injecting Centre, Sydney, Australia.
² Discipline of Addiction Medicine, the Central Clinical School, Sydney Medical School, the Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
³ National Drug and Alcohol Research Centre, UNSW, Sydney, Australia.
⁴ Health Risks Program, Burnet Institute, Melbourne, Australia.
⁵ Monash Addiction Research Centre, Monash University, Melbourne, Australia.

PMID: 35388569
DOI: 10.1111/add.15887

No abstract available

Keywords: Harm reduction; intramuscular naloxone; intranasal naloxone; narcotic antagonists; opioid overdose; take home naloxone.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Overdose* / drug therapy
Humans
Naloxone* / therapeutic use
Narcotic Antagonists / therapeutic use

Substances

Narcotic Antagonists
Naloxone